10 research outputs found
Trasplante de homoinjertos valvulares cardiacos y vasculares
The advances in the manipulation of human tissues,
the development of cryobiology, paediatric cardiac
surgery, the impossibility of obtaining an ideal
prosthetic cardiac valve and the surgical treatment of
cardiovascular infections have revived interest in the
use of homografts. The donors of these homografts
can be: a) Live donors: aortic and pulmonary valve of
the recipient of a heart transplant; b) Multiorgan
donors with a diagnosis of death according to neurological
criteria, whose heart is rejected for heart transplant;
c) Cadaver donors with asystolia of less than 8
hours.
Homograft cardiac valves are the substitute of
choice in aortic valve endocarditis, patients with
counter-indications for anticoagulation, reconstruction
of the outflow tract of the right ventricle, aortic
valve replacement in children and young adults
through the Ross operation, and an optional indication
is the aortic valve and/or rising aorta replacement
in patients over 60 years of age. Although there
are not sufficiently broad series of homogratfs with
arterial substitutes, with respect to the number of
patients and time of evolution, the results suggest
that this can benefit patients with vascular infection,
immunodepressed patients or complex patients
whose technique during the operation might require
a homograft
Dual-source CT for visualization of the coronary arteries in heart transplant patients with high heart rates
OBJECTIVE. The purpose of this study was to evaluate the quality of dual-source CT images of the coronary arteries in heart transplant recipients with high heart rates.
SUBJECTS AND METHODS. Contrast-enhanced dual-source CT coronary angiography was performed on 23 heart transplant recipients (20 men, three women; mean age, 61.1 ± 12.8 years). Data sets were reconstructed in 5% steps from 30% to 80% of the R-R interval. Two blinded independent readers using a 5-point scale (0, not evaluative; 4, excellent quality) assessed the quality of images of coronary segments.
RESULTS. The mean heart rate during scanning was 89.2 ± 10.4 beats/min. Interobserver agreement on the quality of images of the whole coronary tree was a kappa value of 0.78 and for selection of the optimal reconstruction interval was a kappa value of 0.82. The optimal reconstruction interval was systole in 17 (74%) of the 23 of heart transplant recipients. At the best reconstruction interval, diagnostic image quality (score ≥ 2) was obtained in 92.1% (303 of 329) of the coronary artery segments. The mean image quality score for the whole coronary tree was 3.1 ± 1.01. No significant correlation between mean heart rate (ρ = 0.31) or heart rate variability (ρ = 0.23) and overall image quality score was observed (p = not significant).
CONCLUSION. Dual-source CT acquisition yields coronary angiograms of diagnostic quality in heart transplant recipients. Mean heart rate and heart rate variability during scanning do not have a negative effect on the overall quality of images of the coronary arteries
Trasplante cardíaco
A heart transplant is at present considered the
treatment of choice in cases of terminal cardiac insufficiency
refractory to medical or surgical treatment. Due
to factors such as the greater life expectancy of the
population and the more efficient management of acute
coronary syndromes, there is an increasing number of
people who suffer from heart failure. It is estimated
that the prevalence of the disease in developed countries
is around 1%; of this figure, some 10% are in an
advanced stage and are thus potential receptors of a
heart transplant. The problem is that it is still not possible
to offer this therapeutic form to all of the patients
that require it. Consequently, it is necessary to optimise
the results of the heart transplant through the
selection of patients, selection and management of
donors, perioperative management and control of the
disease due to graft rejection. Since the first transplant
carried out in 1967, numerous advances and changes
have taken place, which has made it possible to
increase survival and quality of life of those who have
received a new heart. In this article we review the most
relevant aspects of the heart transplant and the challenges
that are currently faced
Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study
Chronic wounds (VLU: venous leg ulcer, DFU: diabetic foot ulcer, PU: pressure ulcer, or complex wounds) affect a significant proportion of the population. Despite appropriate standard wound care, such ulcers unfortunately may remain open for months or even years. The use of leukocyte- and platelet-rich fibrin (L-PRF) to cure skin ulcers is a simple and inexpensive method, widely used in some countries but unknown or neglected in most others. This auto-controlled prospective cohort study explored and quantified accurately for the first time the adjunctive benefits of topical applications of L-PRF in the management of such refractory ulcers in a diverse group of patients. Forty-four consecutive patients with VLUs (n = 28, 32 wounds: 17 ≤ 10 cm(2) and 15 > 10 cm(2)), DPUs (n = 9, 10 wounds), PUs (n = 5), or complex wounds (n = 2), all refractory to standard treatment for ≥3 months, received a weekly application of L-PRF membranes. L-PRF was prepared following the original L-PRF method developed more than 15 years ago (400g, 12 minutes) using the Intra-Spin L-PRF centrifuge/system and the XPression box kit (Intra-Lock, Boca Raton, FL, USA; the only CE/FDA cleared system for the preparation of L-PRF). Changes in wound area were recorded longitudinally via digital planimetry. Adverse events and pain levels were also registered. All wounds showed significant improvements after the L-PRF therapy. All VLUs ≤ 10 cm(2), all DFUs, as well as the two complex wounds showed full closure within a 3-month period. All wounds of patients with VLUs > 10 cm(2) who continued therapy (10 wounds) could be closed, whereas in the five patients who discontinued therapy improvement of wound size was observed. Two out of the five PUs were closed, with improvement in the remaining three patients who again interrupted therapy (surface evolution from 7.35 ± 4.31 cm(2) to 5.78 ± 3.81 cm(2)). No adverse events were observed. A topical application of L-PRF on chronic ulcers, recalcitrant to standard wound care, promotes healing and wound closure in all patients following the treatment. This new therapy is simple, safe and inexpensive, and should be considered a relevant therapeutic option for all refractory skin ulcers.status: publishe
Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study
Chronic wounds (VLU: venous leg ulcer, DFU: diabetic foot ulcer, PU: pressure ulcer, or complex wounds) affect a significant proportion of the population. Despite appropriate standard wound care, such ulcers unfortunately may remain open for months or even years. The use of leukocyte- and platelet-rich fibrin (L-PRF) to cure skin ulcers is a simple and inexpensive method, widely used in some countries but unknown or neglected in most others. This auto-controlled prospective cohort study explored and quantified accurately for the first time the adjunctive benefits of topical applications of L-PRF in the management of such refractory ulcers in a diverse group of patients. Forty-four consecutive patients with VLUs (n = 28, 32 wounds: 17 ≤ 10 cm2 and 15 > 10 cm2), DPUs (n = 9, 10 wounds), PUs (n = 5), or complex wounds (n = 2), all refractory to standard treatment for ≥3 months, received a weekly application of L-PRF membranes. L-PRF was prepared following the original L-PRF method developed more than 15 years ago (400g, 12 minutes) using the Intra-Spin L-PRF centrifuge/system and the XPression box kit (Intra-Lock, Boca Raton, FL, USA; the only CE/FDA cleared system for the preparation of L-PRF). Changes in wound area were recorded longitudinally via digital planimetry. Adverse events and pain levels were also registered. All wounds showed significant improvements after the L-PRF therapy. All VLUs ≤ 10 cm2, all DFUs, as well as the two complex wounds showed full closure within a 3-month period. All wounds of patients with VLUs > 10 cm2 who continued therapy (10 wounds) could be closed, whereas in the five patients who discontinued therapy improvement of wound size was observed. Two out of the five PUs were closed, with improvement in the remaining three patients who again interrupted therapy (surface evolution from 7.35 ± 4.31 cm2 to 5.78 ± 3.81 cm2). No adverse events were observed. A topical application of L-PRF on chronic ulcers, recalcitrant to standard wound care, promotes healing and wound closure in all patients following the treatment. This new therapy is simple, safe and inexpensive, and should be considered a relevant therapeutic option for all refractory skin ulcers
Dual-source CT for visualization of the coronary arteries in heart transplant patients with high heart rates
OBJECTIVE. The purpose of this study was to evaluate the quality of dual-source CT images of the coronary arteries in heart transplant recipients with high heart rates.
SUBJECTS AND METHODS. Contrast-enhanced dual-source CT coronary angiography was performed on 23 heart transplant recipients (20 men, three women; mean age, 61.1 ± 12.8 years). Data sets were reconstructed in 5% steps from 30% to 80% of the R-R interval. Two blinded independent readers using a 5-point scale (0, not evaluative; 4, excellent quality) assessed the quality of images of coronary segments.
RESULTS. The mean heart rate during scanning was 89.2 ± 10.4 beats/min. Interobserver agreement on the quality of images of the whole coronary tree was a kappa value of 0.78 and for selection of the optimal reconstruction interval was a kappa value of 0.82. The optimal reconstruction interval was systole in 17 (74%) of the 23 of heart transplant recipients. At the best reconstruction interval, diagnostic image quality (score ≥ 2) was obtained in 92.1% (303 of 329) of the coronary artery segments. The mean image quality score for the whole coronary tree was 3.1 ± 1.01. No significant correlation between mean heart rate (ρ = 0.31) or heart rate variability (ρ = 0.23) and overall image quality score was observed (p = not significant).
CONCLUSION. Dual-source CT acquisition yields coronary angiograms of diagnostic quality in heart transplant recipients. Mean heart rate and heart rate variability during scanning do not have a negative effect on the overall quality of images of the coronary arteries
Trasplante cardíaco
A heart transplant is at present considered the
treatment of choice in cases of terminal cardiac insufficiency
refractory to medical or surgical treatment. Due
to factors such as the greater life expectancy of the
population and the more efficient management of acute
coronary syndromes, there is an increasing number of
people who suffer from heart failure. It is estimated
that the prevalence of the disease in developed countries
is around 1%; of this figure, some 10% are in an
advanced stage and are thus potential receptors of a
heart transplant. The problem is that it is still not possible
to offer this therapeutic form to all of the patients
that require it. Consequently, it is necessary to optimise
the results of the heart transplant through the
selection of patients, selection and management of
donors, perioperative management and control of the
disease due to graft rejection. Since the first transplant
carried out in 1967, numerous advances and changes
have taken place, which has made it possible to
increase survival and quality of life of those who have
received a new heart. In this article we review the most
relevant aspects of the heart transplant and the challenges
that are currently faced